T-cell Therapies for HIV
- 4 April 2013
- journal article
- review article
- Published by Taylor & Francis in Immunotherapy
- Vol. 5 (4) , 407-414
Abstract
Antiretroviral therapy has improved the quality of life for HIV+ individuals but efficacy requires strict adherence and treatment is not curative. Recently, the use of T cells as therapeutic agents has been in the spotlight in the settings of post-transplant opportunistic infections and cancer. Whether T-cell therapy can be harnessed for treating HIV remains to be determined but there are a few studies that seek to answer that question. Infusion of ex vivo-expanded HIV-specific T cells showed limited efficacy but no adverse events. Genetically modified T cells expressing CD4 chimeric antigen receptors have recently been shown to have persistence that outperforms chimeric antigen receptors used for cancers. Although the results have not yet been published for many clinical studies using T cells for HIV, preclinical studies and the clinical data that are available highlight the potential for T-cell therapy to decrease or eliminate HIV patients’ dependency on antiretroviral therapy.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (AI36211)
This publication has 48 references indexed in Scilit:
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerNew England Journal of Medicine, 2012
- Zinc-finger Nuclease Editing of Human cxcr4 Promotes HIV-1 CD4+ T Cell Resistance and EnrichmentMolecular Therapy, 2012
- Inducible Apoptosis as a Safety Switch for Adoptive Cell TherapyNew England Journal of Medicine, 2011
- Safer CARSMolecular Therapy, 2010
- RNAi-mediated CCR5 Silencing by LFA-1-targeted Nanoparticles Prevents HIV Infection in BLT MiceMolecular Therapy, 2010
- Preintegration HIV-1 Inhibition by a Combination Lentiviral Vector Containing a Chimeric TRIM5α Protein, a CCR5 shRNA, and a TAR DecoyMolecular Therapy, 2009
- The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infectionJournal of Experimental Medicine, 2009
- Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptorNature Medicine, 2008
- HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotypeProceedings of the National Academy of Sciences, 2007
- Suppression of HIV-specific T cell activity by lymph node CD25+regulatory T cells from HIV-infected individualsProceedings of the National Academy of Sciences, 2007